PARIS -- Transcatheter mitral valve replacement (TMVR) could be the better choice over conservative therapy for secondary (or functional) mitral regurgitation (MR), according to researchers settling ...
The global Transcatheter Mitral Valve Replacement (TMVR) market is witnessing rapid expansion and is expected to grow at a strong CAGR of nearly 20% during the forecast period. The increasing burden ...
Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...
KingstronBio announced today that it completed the first implant of its ProStyle M transcatheter mitral valve replacement ...
A “minimalist” approach to transfemoral valve-in-valve transcatheter mitral valve replacement (TMVR), not unlike the approach commonly used with TAVI, appears to be safe and feasible when compared ...
LISBON, Portugal—Using artificial intelligence (AI)-based CT to screen patients for transcatheter mitral valve replacement (TMVR) is as reliable as screening that uses the traditional core lab ...
SAN FRANCISCO -- For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement ...
Washington, D.C. – MAY 2, 2025 – New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, effective, and resulted in shorter ...
WASHINGTON (January 10, 2023) – In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study ...
Edwards Lifesciences announced Thursday that the California company has completed three first-in-human implants of the company’s transcatheter mitral valve replacement system. But it is not the only ...
Highlife SAS secured CE mark for its transcatheter mitral valve replacement (TMVR) system, bringing a much needed treatment option for patients with limited alternatives. The Highlife TMVR system is ...
Paris, January 26, 2026 – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results